Marinomed Biotech AG (VIE: MARI)
Austria
· Delayed Price · Currency is EUR
15.60
-0.50 (-3.11%)
Dec 20, 2024, 5:35 PM CET
Marinomed Biotech AG Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Cash & Equivalents | 1.86 | 2.59 | 8.18 | 5.8 | 9.21 | 12.02 | Upgrade
|
Cash & Short-Term Investments | 1.86 | 2.59 | 8.18 | 5.8 | 9.21 | 12.02 | Upgrade
|
Cash Growth | -73.57% | -68.33% | 40.90% | -36.98% | -23.40% | 600.65% | Upgrade
|
Accounts Receivable | 1.92 | 1.4 | 1.39 | 3.4 | 2.33 | 1.48 | Upgrade
|
Other Receivables | 0 | 0.98 | 1.73 | 1.41 | 2.85 | 1.68 | Upgrade
|
Receivables | 1.93 | 2.39 | 3.12 | 4.81 | 5.18 | 3.17 | Upgrade
|
Inventory | 1.06 | 1.01 | 1.56 | 1.03 | 0.93 | 0.1 | Upgrade
|
Prepaid Expenses | - | 1.15 | 1.41 | 1.24 | 0.08 | 0.05 | Upgrade
|
Other Current Assets | - | - | -0 | 0 | - | - | Upgrade
|
Total Current Assets | 4.84 | 7.14 | 14.27 | 12.88 | 15.4 | 15.34 | Upgrade
|
Property, Plant & Equipment | 5.85 | 5.94 | 6.2 | 6.43 | 3.07 | 0.67 | Upgrade
|
Long-Term Investments | - | - | - | - | - | 0.04 | Upgrade
|
Other Intangible Assets | 1.46 | 0.14 | 0.2 | 0.18 | 0.2 | 0.1 | Upgrade
|
Long-Term Deferred Charges | - | 1.38 | 1.61 | 1.83 | 1.86 | 1.52 | Upgrade
|
Other Long-Term Assets | 0.01 | 0.01 | 0.01 | 0.02 | 2.97 | 1.84 | Upgrade
|
Total Assets | 12.15 | 14.61 | 22.29 | 21.34 | 23.5 | 19.5 | Upgrade
|
Accounts Payable | 0.58 | 1.53 | 1.15 | 1.99 | 1.98 | 1 | Upgrade
|
Accrued Expenses | - | 0.71 | 0.82 | 1.54 | 1.18 | 1.39 | Upgrade
|
Current Portion of Long-Term Debt | 0.6 | 6.96 | 2.45 | 0.74 | 0.34 | 0.06 | Upgrade
|
Current Portion of Leases | - | - | - | 0.02 | 0.01 | 0.08 | Upgrade
|
Current Unearned Revenue | 1.41 | 0.09 | 0.84 | 1.39 | 0.85 | 0.05 | Upgrade
|
Other Current Liabilities | - | 0.37 | 0.7 | 0.34 | 1.25 | 1.45 | Upgrade
|
Total Current Liabilities | 2.58 | 9.65 | 5.96 | 6.01 | 5.61 | 4.03 | Upgrade
|
Long-Term Debt | 21.15 | 14.84 | 20.18 | 15.01 | 12.44 | 4.48 | Upgrade
|
Long-Term Leases | - | - | - | 0.04 | 0.02 | 0.03 | Upgrade
|
Long-Term Unearned Revenue | 0.26 | 0.25 | 0.3 | 0.09 | 0.08 | 0.1 | Upgrade
|
Other Long-Term Liabilities | 0 | - | - | -0 | - | - | Upgrade
|
Total Liabilities | 23.99 | 24.75 | 26.44 | 21.15 | 18.14 | 8.64 | Upgrade
|
Common Stock | 1.54 | 1.52 | 1.51 | 1.48 | 1.47 | 1.47 | Upgrade
|
Retained Earnings | -58.68 | -56.55 | -49.76 | -43.36 | -37.47 | -31.45 | Upgrade
|
Comprehensive Income & Other | 45.3 | 44.89 | 44.09 | 42.07 | 41.35 | 40.85 | Upgrade
|
Shareholders' Equity | -11.84 | -10.14 | -4.16 | 0.19 | 5.36 | 10.87 | Upgrade
|
Total Liabilities & Equity | 12.15 | 14.61 | 22.29 | 21.34 | 23.5 | 19.5 | Upgrade
|
Total Debt | 21.75 | 21.8 | 22.63 | 15.8 | 12.81 | 4.64 | Upgrade
|
Net Cash (Debt) | -19.89 | -19.21 | -14.45 | -10 | -3.61 | 7.38 | Upgrade
|
Net Cash Per Share | - | -12.65 | -9.64 | -6.77 | -2.45 | 5.20 | Upgrade
|
Filing Date Shares Outstanding | - | 1.54 | 1.52 | 1.49 | 1.47 | 1.47 | Upgrade
|
Total Common Shares Outstanding | - | 1.52 | 1.51 | 1.48 | 1.47 | 1.47 | Upgrade
|
Working Capital | 2.26 | -2.52 | 8.31 | 6.86 | 9.79 | 11.31 | Upgrade
|
Book Value Per Share | - | -6.65 | -2.76 | 0.13 | 3.64 | 7.39 | Upgrade
|
Tangible Book Value | -13.3 | -10.28 | -4.35 | 0.01 | 5.16 | 10.76 | Upgrade
|
Tangible Book Value Per Share | - | -6.74 | -2.89 | 0.01 | 3.51 | 7.32 | Upgrade
|
Land | - | 5.91 | 5.91 | 5.89 | 2.65 | 0.36 | Upgrade
|
Machinery | - | 1.44 | 1.31 | 1.26 | 0.84 | 0.57 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.